ReviewJournal of clinical medicine2023

Targeting PCSK9 and Beyond for the Management of Low-Density Lipoprotein Cholesterol.

Farzahna Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.